Product image of Monroltec (Sodium Molybdate (99mo)) supplied by GNH India

Monroltec

Active Ingredient:
Sodium Molybdate (99mo)
Origin:
EU

Monroltec (Sodium Molybdate (99mo))

Sodium Molybdate, the active ingredient in Monroltec, is a radiopharmaceutical presented as a sterile solution for intravenous or ocular use. It provides a source of technetium‑99m for gamma‑camera imaging in diagnostic procedures.

GNH India supplies Monroltec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Monrol Europe Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Monroltec is used in nuclear medicine to generate technetium‑99m for imaging of specific organ systems.

  • Bone scintigraphy: enables visualization of skeletal metabolism and detection of metastases.
  • Cardiac perfusion imaging: assesses myocardial blood flow and identifies ischemic regions.
  • Renal function imaging: evaluates renal perfusion and excretory function using dynamic scans.

How It Works

  • Sodium Molybdate serves as a molybdenum‑99 generator; the Mo‑99 isotope decays to technetium‑99m, a gamma‑emitting radionuclide. After intravenous or ocular administration, the released technetium‑99m binds to specific radiopharmaceutical kits, allowing targeted imaging of bone, heart, kidney or other tissues with a gamma camera.

Side Effects

Monroltec may cause a range of adverse reactions following administration.

Common Side Effects

  • Injection site pain: mild discomfort at the site of IV or ocular delivery.
  • Flushing: transient redness and warmth.
  • Nausea: occasional mild gastrointestinal upset.
  • Headache: brief, self‑limiting.
  • Mild allergic reaction: rash or itching.
  • Transient hypotension: brief drop in blood pressure.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic response requiring immediate medical attention.
  • Severe hypotension: prolonged low blood pressure.
  • Radiation‑induced skin injury: localized erythema at injection site.
  • Organ toxicity: rare renal or hepatic impairment.
  • Hematologic effects: transient changes in blood counts.
  • Severe allergic reaction: bronchospasm or angioedema.

Precautions & Warnings

Before using Monroltec, clinicians should consider several safety measures.

  • Verify patient identity: confirm correct patient and indication.
  • Assess renal function: ensure adequate clearance for imaging agents.
  • Review allergy history: check for prior reactions to radiopharmaceuticals.
  • Ensure radiopharmacy compliance: follow GMP and shielding protocols.
  • Monitor vital signs: observe blood pressure and heart rate during and after administration.
  • Store at ambient temperature: keep in original shielding container, protect from light and moisture.

Avoid Interactions

Monroltec may interact with other agents that influence radionuclide uptake or distribution.

Major Interactions (Avoid)

  • Iodine‑containing contrast agents: can interfere with technetium uptake and image quality.
  • Antithyroid medications: may alter thyroid imaging results.
  • Strong chelating agents (e.g., DTPA): bind technetium and reduce diagnostic efficacy.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may affect cardiac perfusion imaging interpretation.
  • Diuretics: can modify renal scan dynamics.
  • Calcium supplements: may compete with bone‑seeking tracers.
  • Thyroid hormone therapy: influences thyroid uptake studies.
  • Certain antibiotics (e.g., sulfonamides): may cause mild alterations in biodistribution.

Frequently Asked Questions

Monroltec is a radiopharmaceutical that provides molybdenum‑99, which decays to technetium‑99m. The resulting technetium‑99m is used in gamma‑camera imaging for diagnostic procedures such as bone scans, cardiac perfusion studies, and renal function assessments.

Sodium molybdate acts as a generator of the isotope molybdenum‑99. After administration, Mo‑99 decays to technetium‑99m, a gamma‑emitting radionuclide that can be attached to specific imaging kits, allowing targeted visualization of organs or tissues with a gamma camera.

The dose of Monroltec is determined by the prescribing physician or nuclear medicine specialist based on the specific imaging protocol, patient characteristics, and the intended diagnostic study. No standard dosing regimen is provided here.

The safety of Monroltec in pregnancy or lactation has not been fully established. Use is generally avoided unless the diagnostic benefit outweighs potential risks, and decisions should be made by the treating physician in consultation with the patient.

To order Monroltec, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Monroltec (sodium molybdate) is a molybdenum‑99 generator similar to other commercially available generators. Its performance, purity and radiochemical yield are comparable, but specific differences may exist in formulation, shelf‑life, and regulatory status, which should be evaluated by the purchasing institution.

Monroltec should be stored at ambient temperature, protected from light and moisture, and kept in its original shielding container. Follow all radiopharmacy safety guidelines, and avoid freezing or shaking the product.

Monroltec is administered by a qualified healthcare professional either intravenously or via ocular injection, depending on the intended imaging study. Proper aseptic technique and radiation safety precautions must be observed during administration.

Serious risks include severe allergic reactions such as anaphylaxis, significant hypotension, radiation‑induced skin injury at the injection site, and rare organ toxicity. Immediate medical attention is required if any of these events occur.

Monroltec should not be used in patients with known hypersensitivity to sodium molybdate or any component of the formulation, in individuals with uncontrolled severe hypotension, or in situations where the diagnostic benefit does not outweigh the potential radiation exposure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Molybdate (99mo)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT